A carregar...
VHL and Hypoxia Signaling: Beyond HIF in Cancer
Von Hippel-Lindau (VHL) is an important tumor suppressor that is lost in the majority of clear cell carcinoma of renal cancer (ccRCC). Its regulatory pathway involves the activity of E3 ligase, which targets hypoxia inducible factor α (including HIF1α and HIF2α) for proteasome degradation. In recent...
Na minha lista:
| Publicado no: | Biomedicines |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5874692/ https://ncbi.nlm.nih.gov/pubmed/29562667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines6010035 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|